Recent Changes in Breast Cancer Incidence in Spain, 1980–2004

Background Since the 1980s, Spain experienced two decades of sharply increasing breast cancer incidence. Declines in breast cancer incidence have recently been reported in many developed countries. We examined whether a similar downturn might have taken place in Spain in recent years. Methods Cases of invasive female breast cancer were drawn from all population-based Spanish cancer registries that had at least 10 years of uninterrupted registration over the period 1980–2004. Overall and age-specific changes in incidence rates were evaluated using change-point Poisson models, which allow for accurate detection and estimation of trend changes. All statistical tests were two-sided. Results A total of 80 453 incident cases of invasive breast cancer were identified. Overall age- and registry-adjusted incidence rates rose by 2.9% (95% confidence interval [CI] = 2.7% to 3.1%) annually during the 1980s and 1990s; there was a statistically significant change in this trend in 2001 (95% CI = 1998 to 2004; P value for the existence of a change point <.001), after which incidence declined annually by 3.0% (95% CI = 1.8% to 4.1%). This trend differed by age group: There was a steady increase in incidence for women younger than 45 years, an abrupt downturn in 2001 for women aged 45–64 years, and a gradual leveling off in 1995 for women aged 65 years or older. Separate analyses for registries that had at least 15 years of uninterrupted registration detected a statistically significant interruption of the previous upward trend in breast cancer incidence in provinces that had aggressive breast cancer screening programs and high screening participation rates, including Navarra (change point = 1991, P < .001), Granada (change point = 2002, P = .003), Bizkaia (change point = 1998, P < .001), Gipuzkoa (change point = 1998, P = .001), and Araba (change point = 1997, P = .002). Conclusions The recent downturn in breast cancer incidence among Spanish women older than 45 years is best explained by a period effect linked to screening saturation.

[1]  J. Manson,et al.  Breast cancer after use of estrogen plus progestin in postmenopausal women. , 2009, The New England journal of medicine.

[2]  Helen Farrugia,et al.  Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia , 2009, The Medical journal of Australia.

[3]  J. Otten,et al.  Impressive time‐related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975‐2006 , 2008, International journal of cancer.

[4]  M. Kumle Declining breast cancer incidence and decreased HRT use , 2008, The Lancet.

[5]  J. Marks,et al.  Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Ferlay,et al.  Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  B. Macmahon,et al.  Is the incidence of breast cancer declining? , 2008, Epidemiology.

[8]  R. Rawal,et al.  Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy , 2008, Breast Cancer Research and Treatment.

[9]  D. Miglioretti,et al.  Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. , 2007, Journal of the National Cancer Institute.

[10]  Robert N Hoover,et al.  Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. , 2007, Journal of the National Cancer Institute.

[11]  J. Daling,et al.  Changes in Breast Cancer Incidence Rates in the United States by Histologic Subtype and Race/Ethnicity, 1995 to 2004 , 2007, Cancer Epidemiology Biomarkers & Prevention.

[12]  J. Coebergh,et al.  Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Coebergh,et al.  On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk , 2007, Breast Cancer Research and Treatment.

[14]  Bingshu E. Chen,et al.  Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers , 2007, Cancer Causes & Control.

[15]  J. Bulliard,et al.  Trends in breast cancer incidence among women under the age of forty , 2007, British Journal of Cancer.

[16]  E. Kliewer,et al.  A decline in breast-cancer incidence. , 2007, The New England journal of medicine.

[17]  Michael J Thun,et al.  Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women , 2007, Breast Cancer Research.

[18]  Eric J Feuer,et al.  The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.

[19]  Bingshu E. Chen,et al.  Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions , 2007, Cancer Causes & Control.

[20]  D. M. Parkin,et al.  Use of Statistics to Assess the Global Burden of Breast Cancer , 2006, The breast journal.

[21]  L. Serra-Majem,et al.  [Prevalence of obesity in Spain]. , 2005, Medicina clinica.

[22]  J. Aranceta-bartrina,et al.  Prevalencia de obesidad en España , 2005 .

[23]  A. Miller,et al.  Age at menarche in relation to adult height: the EPIC study. , 2005, American journal of epidemiology.

[24]  Kari Kuulasmaa,et al.  Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. , 2004, Maturitas.

[25]  Mark Garton,et al.  Breast cancer and hormone-replacement therapy: the Million Women Study , 2003, The Lancet.

[26]  F. Bray,et al.  Breast cancer incidence and mortality trends in 16 European countries. , 2003, European journal of cancer.

[27]  Roberto Pastor-Barriuso,et al.  Transition models for change‐point estimation in logistic regression , 2003, Statistics in medicine.

[28]  A. Miller,et al.  Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2002, Public Health Nutrition.

[29]  C. Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[30]  Hyune-Ju Kim,et al.  Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .

[31]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[32]  Xavier Bosch,et al.  barcelona Investigating the reasons for Spain's falling birth rate , 1998, The Lancet.

[33]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1997 .

[34]  P. McCullagh,et al.  Generalized Linear Models , 1992 .

[35]  P. McCullagh,et al.  Generalized Linear Models , 1984 .

[36]  S D Walter,et al.  Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.

[37]  K. Worsley An improved Bonferroni inequality and applications , 1982 .

[38]  Books Received,et al.  Notes , 1921, Nature.

[39]  A. Weill,et al.  [Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend]. , 2008, Bulletin du cancer.

[40]  A. Weill,et al.  Baisse de l’incidence des cancers du sein en 2005 et 2006 en France : un phénomène paradoxal , 2008 .

[41]  L. Shulman The Decrease in Breast-Cancer Incidence in 2003 in the United States , 2008 .

[42]  S. Rosso,et al.  Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. , 2007, Journal of the National Cancer Institute.

[43]  Carmen Rodríguez Blas Encuesta Nacional de Salud , 2007 .

[44]  G. Elfenbein A decline in breast-cancer incidence. , 2007, The New England journal of medicine.

[45]  Andrés Arroyo Pérez Tendencias demográficas durante el siglo XX en España , 2003 .

[46]  T. Vega Alonso,et al.  [Hormonal replacement therapy in Spain]. , 2002, Medicina clinica.

[47]  H. Schneider,et al.  Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. , 1997, International journal of fertility and women's medicine.

[48]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.